Shares in Angel Studios (ANGX) soared 7% higher today after a leading analyst said a swathe of new films could lead to a cinematic bounceback for it and other movie stocks over the next 12 months and beyond.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Pre-COVID Release Figures
Drew Crum, analyst at B. Riley Securities, reiterated his Buy rating and $7 price target on ANGX and his Buy rating and $46 price target on IMAX Corporation (IMAX)
Crum said he had just attended CinemaCon 2026, the world’s largest trade show for the motion picture industry. “In summary, sentiment was positive [due to] factors such as improving supply of releases returning to pre-COVID levels, encouraging developments regarding labor negotiations with studios, while presentations from the major studios showcasing upcoming films provided additional visibility on the Hollywood slate.”
Films he is optimistic about in 2027 include The Thomas Crown Affair, The Legend of Zelda and The Hunt for Gollum. However, one title that was “conspicuously absent” was Warner Bros’ The Batman: Part II.
Paramount Could Harm the Industry
He added that Paramount-Skydance’s (PSKY) bid to acquire Warner Bros. (WBD) was a key talking point at the event, with some people stating the deal would be “harmful” to the industry. “There was also prevailing skepticism that the newco could achieve its target of releasing 30 films per year. That said, the market appears to have accepted the transaction.”
Overall, he said the “tone was upbeat and we came away positive on the industry’s near-term prospects.”
Angel Studios is the company behind The Chosen and other crowdfunded hits, and is building an entertainment model driven by its community. Instead of relying on traditional studios, Angel uses fan-funded projects and low-budget production to create shows and films that already have built‑in audiences. Although not as reliant on the Hollywood slate mentioned by Crum, it is likely to feel the benefit of a more confident industry.
Its share price is, however, down 42% so far this year.
Is ANGX a Good Stock to Buy Now?
On TipRanks, ANGX has a Strong Buy consensus based on 6 Buy ratings. Its highest price target is $9. ANGX stock’s consensus price target is $7.83, implying a 190.54% upside.
